HEADER RETINOIC ACID-BINDING PROTEIN 10-FEB-13 4J5W TITLE CRYSTAL STRUCTURE OF THE APO-PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2, NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1, ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR, STEROID AND XENOBIOTIC RECEPTOR, SXR, NCOA-1, COMPND 7 CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, BHLHE74, PROTEIN HIN-2, COMPND 8 RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, STEROID RECEPTOR COMPND 9 COACTIVATOR 1, SRC-1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 2; COMPND 13 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA, NUCLEAR RECEPTOR COMPND 14 COACTIVATOR 1; COMPND 15 CHAIN: C, D; COMPND 16 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 2 GROUP B MEMBER 1, RETINOID X COMPND 17 RECEPTOR ALPHA, NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, COMPND 18 BHLHE74, PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, COMPND 19 STEROID RECEPTOR COACTIVATOR 1, SRC-1; COMPND 20 EC: 2.3.1.48; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BHLHE74, NCOA1, NR1I2, PXR, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-AI (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BHLHE74, NCOA1, NR2B1, RXRA, SRC1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21-AI (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET30B KEYWDS PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING KEYWDS 2 DOMAIN, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, UNIQUE KEYWDS 3 INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, KEYWDS 4 UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING KEYWDS 5 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.D.WALLACE,L.BETTS,M.R.REDINBO REVDAT 4 28-FEB-24 4J5W 1 REMARK SEQADV REVDAT 3 15-NOV-17 4J5W 1 REMARK REVDAT 2 16-AUG-17 4J5W 1 SOURCE REVDAT 1 21-AUG-13 4J5W 0 JRNL AUTH B.D.WALLACE,L.BETTS,G.TALMAGE,R.M.POLLET,N.S.HOLMAN, JRNL AUTH 2 M.R.REDINBO JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE HUMAN NUCLEAR JRNL TITL 2 XENOBIOTIC RECEPTOR PXR IN COMPLEX WITH RXRALPHA. JRNL REF J.MOL.BIOL. V. 425 2561 2013 JRNL REFN ISSN 0022-2836 JRNL PMID 23602807 JRNL DOI 10.1016/J.JMB.2013.04.012 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8_1061 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 31721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1565 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5428 - 6.2235 0.99 3031 146 0.2326 0.2964 REMARK 3 2 6.2235 - 4.9414 0.99 2847 163 0.2599 0.2603 REMARK 3 3 4.9414 - 4.3172 0.99 2832 153 0.2192 0.2515 REMARK 3 4 4.3172 - 3.9227 0.98 2790 152 0.2146 0.2632 REMARK 3 5 3.9227 - 3.6416 0.97 2782 125 0.2363 0.3041 REMARK 3 6 3.6416 - 3.4270 0.97 2729 144 0.2525 0.2771 REMARK 3 7 3.4270 - 3.2554 0.97 2741 160 0.2690 0.3406 REMARK 3 8 3.2554 - 3.1137 0.96 2723 127 0.2863 0.3177 REMARK 3 9 3.1137 - 2.9938 0.95 2723 122 0.2966 0.3940 REMARK 3 10 2.9938 - 2.8905 0.92 2543 123 0.3006 0.3939 REMARK 3 11 2.8905 - 2.8000 0.87 2415 150 0.3075 0.3488 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 8593 REMARK 3 ANGLE : 0.880 11580 REMARK 3 CHIRALITY : 0.059 1295 REMARK 3 PLANARITY : 0.004 1478 REMARK 3 DIHEDRAL : 15.602 3267 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4J5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077635. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL WITH K-B BIOMORPH REMARK 200 MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34037 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.773 REMARK 200 RESOLUTION RANGE LOW (A) : 92.067 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20% PEG 8000, 0.1-0.2 M MGCL, 0.1 M REMARK 280 BIS-TRIS PROPRANE, 0.02% SODIUM AZIDE, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.94000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.77500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.94000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.77500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 127 REMARK 465 ASN A 128 REMARK 465 ALA A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 GLY A 435 REMARK 465 GLY A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 SER A 440 REMARK 465 SER A 441 REMARK 465 HIS A 442 REMARK 465 SER A 462 REMARK 465 SER B 127 REMARK 465 ASN B 128 REMARK 465 ALA B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 138 REMARK 465 GLY B 139 REMARK 465 VAL B 140 REMARK 465 LEU B 178 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 SER B 192 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 GLY B 314 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 GLY B 435 REMARK 465 GLY B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 SER B 440 REMARK 465 SER B 441 REMARK 465 HIS B 442 REMARK 465 SER B 462 REMARK 465 THR C 246 REMARK 465 GLU C 247 REMARK 465 THR C 248 REMARK 465 TYR C 249 REMARK 465 VAL C 250 REMARK 465 GLU C 251 REMARK 465 ALA C 252 REMARK 465 ASN C 253 REMARK 465 MET C 254 REMARK 465 GLY C 255 REMARK 465 LEU C 256 REMARK 465 ASN C 257 REMARK 465 PRO C 258 REMARK 465 SER C 259 REMARK 465 SER C 260 REMARK 465 PRO C 458 REMARK 465 HIS C 459 REMARK 465 GLN C 460 REMARK 465 MET C 461 REMARK 465 THR C 462 REMARK 465 GLY C 463 REMARK 465 GLY C 464 REMARK 465 SER C 465 REMARK 465 GLY C 466 REMARK 465 GLY C 467 REMARK 465 SER C 468 REMARK 465 SER C 469 REMARK 465 HIS C 470 REMARK 465 SER C 471 REMARK 465 SER C 472 REMARK 465 LEU C 473 REMARK 465 THR C 474 REMARK 465 GLU C 475 REMARK 465 ARG C 476 REMARK 465 GLY C 487 REMARK 465 SER C 488 REMARK 465 PRO C 489 REMARK 465 SER C 490 REMARK 465 THR D 246 REMARK 465 GLU D 247 REMARK 465 THR D 248 REMARK 465 TYR D 249 REMARK 465 VAL D 250 REMARK 465 GLU D 251 REMARK 465 ALA D 252 REMARK 465 ASN D 253 REMARK 465 MET D 254 REMARK 465 GLY D 255 REMARK 465 LEU D 256 REMARK 465 ASN D 257 REMARK 465 PRO D 258 REMARK 465 SER D 259 REMARK 465 SER D 260 REMARK 465 PRO D 458 REMARK 465 HIS D 459 REMARK 465 GLN D 460 REMARK 465 MET D 461 REMARK 465 THR D 462 REMARK 465 GLY D 463 REMARK 465 GLY D 464 REMARK 465 SER D 465 REMARK 465 GLY D 466 REMARK 465 GLY D 467 REMARK 465 SER D 468 REMARK 465 SER D 469 REMARK 465 HIS D 470 REMARK 465 SER D 471 REMARK 465 SER D 472 REMARK 465 LEU D 473 REMARK 465 THR D 474 REMARK 465 GLU D 475 REMARK 465 GLY D 487 REMARK 465 SER D 488 REMARK 465 PRO D 489 REMARK 465 SER D 490 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 458 CG CD OE1 OE2 REMARK 470 GLU B 235 CG CD OE1 OE2 REMARK 470 PHE B 315 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 458 CG CD OE1 OE2 REMARK 470 ASN D 227 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 218 O HOH B 544 1.58 REMARK 500 OD1 ASP B 219 OG SER B 221 1.85 REMARK 500 OD2 ASP B 352 O HOH B 508 2.15 REMARK 500 OG SER C 290 O HOH C 601 2.16 REMARK 500 OE1 GLU C 366 NH1 ARG C 414 2.17 REMARK 500 CD GLU B 218 O HOH B 544 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 354 C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 209 44.81 -107.89 REMARK 500 SER A 231 -93.92 -117.03 REMARK 500 THR A 311 -30.25 -143.11 REMARK 500 HIS A 418 81.79 -157.92 REMARK 500 PHE A 420 -19.25 -156.11 REMARK 500 HIS A 449 45.05 -143.40 REMARK 500 SER A 460 22.54 87.55 REMARK 500 ASN B 171 16.40 57.63 REMARK 500 GLU B 218 1.68 87.19 REMARK 500 LYS B 234 -10.02 82.25 REMARK 500 GLN B 383 125.29 67.11 REMARK 500 HIS B 418 83.36 -154.38 REMARK 500 PHE B 420 -23.24 -148.06 REMARK 500 LYS C 321 -117.57 -74.77 REMARK 500 LEU C 353 -61.89 -120.41 REMARK 500 ASP C 379 33.34 -90.02 REMARK 500 ASN C 385 81.86 -160.40 REMARK 500 ALA C 387 -53.60 -28.31 REMARK 500 ASP C 448 -15.35 78.73 REMARK 500 THR C 449 -64.75 60.61 REMARK 500 LEU C 455 47.03 -92.72 REMARK 500 GLU D 243 -61.68 -152.47 REMARK 500 PRO D 244 84.49 -3.85 REMARK 500 ASP D 263 83.90 44.95 REMARK 500 HIS D 288 -9.93 70.52 REMARK 500 LEU D 353 -68.60 -107.41 REMARK 500 HIS D 477 -29.66 -153.25 REMARK 500 LYS D 478 -83.07 89.32 REMARK 500 LEU D 483 -3.19 -53.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG B 216 GLY B 217 34.09 REMARK 500 GLU B 218 ASP B 219 139.95 REMARK 500 GLU D 243 PRO D 244 -142.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG D 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4J5X RELATED DB: PDB DBREF 4J5W A 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 4J5W A 440 462 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 4J5W B 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 4J5W B 440 462 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 4J5W C 227 462 UNP P19793 RXRA_HUMAN 227 462 DBREF 4J5W C 468 490 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 4J5W D 227 462 UNP P19793 RXRA_HUMAN 227 462 DBREF 4J5W D 468 490 UNP Q15788 NCOA1_HUMAN 678 700 SEQADV 4J5W SER A 127 UNP O75469 EXPRESSION TAG SEQADV 4J5W ASN A 128 UNP O75469 EXPRESSION TAG SEQADV 4J5W ALA A 129 UNP O75469 EXPRESSION TAG SEQADV 4J5W GLY A 435 UNP Q15788 LINKER SEQADV 4J5W GLY A 436 UNP Q15788 LINKER SEQADV 4J5W SER A 437 UNP Q15788 LINKER SEQADV 4J5W GLY A 438 UNP Q15788 LINKER SEQADV 4J5W GLY A 439 UNP Q15788 LINKER SEQADV 4J5W SER B 127 UNP O75469 EXPRESSION TAG SEQADV 4J5W ASN B 128 UNP O75469 EXPRESSION TAG SEQADV 4J5W ALA B 129 UNP O75469 EXPRESSION TAG SEQADV 4J5W GLY B 435 UNP Q15788 LINKER SEQADV 4J5W GLY B 436 UNP Q15788 LINKER SEQADV 4J5W SER B 437 UNP Q15788 LINKER SEQADV 4J5W GLY B 438 UNP Q15788 LINKER SEQADV 4J5W GLY B 439 UNP Q15788 LINKER SEQADV 4J5W GLY C 463 UNP P19793 LINKER SEQADV 4J5W GLY C 464 UNP P19793 LINKER SEQADV 4J5W SER C 465 UNP P19793 LINKER SEQADV 4J5W GLY C 466 UNP Q15788 LINKER SEQADV 4J5W GLY C 467 UNP Q15788 LINKER SEQADV 4J5W GLY D 463 UNP P19793 LINKER SEQADV 4J5W GLY D 464 UNP P19793 LINKER SEQADV 4J5W SER D 465 UNP P19793 LINKER SEQADV 4J5W GLY D 466 UNP Q15788 LINKER SEQADV 4J5W GLY D 467 UNP Q15788 LINKER SEQRES 1 A 336 SER ASN ALA SER GLU ARG THR GLY THR GLN PRO LEU GLY SEQRES 2 A 336 VAL GLN GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG SEQRES 3 A 336 GLU LEU MET ASP ALA GLN MET LYS THR PHE ASP THR THR SEQRES 4 A 336 PHE SER HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SEQRES 5 A 336 SER SER GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SEQRES 6 A 336 SER ARG GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS SEQRES 7 A 336 ASP LEU CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY SEQRES 8 A 336 GLU ASP GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SEQRES 9 A 336 SER GLY GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET SEQRES 10 A 336 ALA ASP MET SER THR TYR MET PHE LYS GLY ILE ILE SER SEQRES 11 A 336 PHE ALA LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE SEQRES 12 A 336 GLU ASP GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU SEQRES 13 A 336 LEU CYS GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU SEQRES 14 A 336 THR GLY THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU SEQRES 15 A 336 GLU ASP THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU SEQRES 16 A 336 PRO MET LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN SEQRES 17 A 336 LEU HIS GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER SEQRES 18 A 336 LEU PHE SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG SEQRES 19 A 336 VAL VAL ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU SEQRES 20 A 336 LYS SER TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS SEQRES 21 A 336 ARG PHE LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU SEQRES 22 A 336 LEU ARG SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU SEQRES 23 A 336 ARG ILE GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET SEQRES 24 A 336 GLN GLU LEU PHE GLY ILE THR GLY SER GLY GLY SER GLY SEQRES 25 A 336 GLY SER SER HIS SER SER LEU THR GLU ARG HIS LYS ILE SEQRES 26 A 336 LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 B 336 SER ASN ALA SER GLU ARG THR GLY THR GLN PRO LEU GLY SEQRES 2 B 336 VAL GLN GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG SEQRES 3 B 336 GLU LEU MET ASP ALA GLN MET LYS THR PHE ASP THR THR SEQRES 4 B 336 PHE SER HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SEQRES 5 B 336 SER SER GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SEQRES 6 B 336 SER ARG GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS SEQRES 7 B 336 ASP LEU CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY SEQRES 8 B 336 GLU ASP GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SEQRES 9 B 336 SER GLY GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET SEQRES 10 B 336 ALA ASP MET SER THR TYR MET PHE LYS GLY ILE ILE SER SEQRES 11 B 336 PHE ALA LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE SEQRES 12 B 336 GLU ASP GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU SEQRES 13 B 336 LEU CYS GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU SEQRES 14 B 336 THR GLY THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU SEQRES 15 B 336 GLU ASP THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU SEQRES 16 B 336 PRO MET LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN SEQRES 17 B 336 LEU HIS GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER SEQRES 18 B 336 LEU PHE SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG SEQRES 19 B 336 VAL VAL ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU SEQRES 20 B 336 LYS SER TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS SEQRES 21 B 336 ARG PHE LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU SEQRES 22 B 336 LEU ARG SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU SEQRES 23 B 336 ARG ILE GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET SEQRES 24 B 336 GLN GLU LEU PHE GLY ILE THR GLY SER GLY GLY SER GLY SEQRES 25 B 336 GLY SER SER HIS SER SER LEU THR GLU ARG HIS LYS ILE SEQRES 26 B 336 LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 C 264 ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU ALA GLU SEQRES 2 C 264 LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL GLU ALA SEQRES 3 C 264 ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP PRO VAL SEQRES 4 C 264 THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU PHE THR SEQRES 5 C 264 LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SER GLU SEQRES 6 C 264 LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG ALA GLY SEQRES 7 C 264 TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS ARG SER SEQRES 8 C 264 ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR GLY LEU SEQRES 9 C 264 HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY VAL GLY SEQRES 10 C 264 ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SER LYS SEQRES 11 C 264 MET ARG ASP MET GLN MET ASP LYS THR GLU LEU GLY CYS SEQRES 12 C 264 LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER LYS GLY SEQRES 13 C 264 LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG GLU LYS SEQRES 14 C 264 VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS LYS TYR SEQRES 15 C 264 PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU LEU ARG SEQRES 16 C 264 LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS LEU GLU SEQRES 17 C 264 HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR PRO ILE SEQRES 18 C 264 ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO HIS GLN SEQRES 19 C 264 MET THR GLY GLY SER GLY GLY SER SER HIS SER SER LEU SEQRES 20 C 264 THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU SEQRES 21 C 264 GLY SER PRO SER SEQRES 1 D 264 ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU ALA GLU SEQRES 2 D 264 LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL GLU ALA SEQRES 3 D 264 ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP PRO VAL SEQRES 4 D 264 THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU PHE THR SEQRES 5 D 264 LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SER GLU SEQRES 6 D 264 LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG ALA GLY SEQRES 7 D 264 TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS ARG SER SEQRES 8 D 264 ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR GLY LEU SEQRES 9 D 264 HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY VAL GLY SEQRES 10 D 264 ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SER LYS SEQRES 11 D 264 MET ARG ASP MET GLN MET ASP LYS THR GLU LEU GLY CYS SEQRES 12 D 264 LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER LYS GLY SEQRES 13 D 264 LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG GLU LYS SEQRES 14 D 264 VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS LYS TYR SEQRES 15 D 264 PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU LEU ARG SEQRES 16 D 264 LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS LEU GLU SEQRES 17 D 264 HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR PRO ILE SEQRES 18 D 264 ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO HIS GLN SEQRES 19 D 264 MET THR GLY GLY SER GLY GLY SER SER HIS SER SER LEU SEQRES 20 D 264 THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU SEQRES 21 D 264 GLY SER PRO SER HET MG C 501 1 HET MG D 501 1 HETNAM MG MAGNESIUM ION FORMUL 5 MG 2(MG 2+) FORMUL 7 HOH *175(H2 O) HELIX 1 1 THR A 144 PHE A 162 1 19 HELIX 2 2 GLU A 194 SER A 208 1 15 HELIX 3 3 GLY A 233 PHE A 237 5 5 HELIX 4 4 LEU A 239 ILE A 261 1 23 HELIX 5 5 ILE A 261 LEU A 267 1 7 HELIX 6 6 PRO A 268 VAL A 291 1 24 HELIX 7 7 GLU A 321 LYS A 332 1 12 HELIX 8 8 HIS A 336 PHE A 349 1 14 HELIX 9 9 GLN A 358 ARG A 381 1 24 HELIX 10 10 PHE A 388 HIS A 418 1 31 HELIX 11 11 THR A 422 PHE A 429 1 8 HELIX 12 12 SER A 444 HIS A 449 1 6 HELIX 13 13 HIS A 449 LEU A 456 1 8 HELIX 14 14 THR B 144 PHE B 162 1 19 HELIX 15 15 GLU B 194 LEU B 209 1 16 HELIX 16 16 LEU B 239 ILE B 261 1 23 HELIX 17 17 ILE B 261 ASP B 266 1 6 HELIX 18 18 PRO B 268 THR B 290 1 23 HELIX 19 19 PHE B 315 LEU B 319 5 5 HELIX 20 20 GLU B 321 LEU B 333 1 13 HELIX 21 21 HIS B 336 PHE B 349 1 14 HELIX 22 22 GLN B 358 ARG B 381 1 24 HELIX 23 23 PHE B 388 HIS B 418 1 31 HELIX 24 24 THR B 422 PHE B 429 1 8 HELIX 25 25 SER B 444 HIS B 449 1 6 HELIX 26 26 HIS B 449 LEU B 456 1 8 HELIX 27 27 PRO C 231 ALA C 241 1 11 HELIX 28 28 ASP C 263 ARG C 285 1 23 HELIX 29 29 PRO C 293 SER C 317 1 25 HELIX 30 30 HIS C 333 GLY C 341 1 9 HELIX 31 31 VAL C 342 LEU C 353 1 12 HELIX 32 32 LEU C 353 MET C 360 1 8 HELIX 33 33 ASP C 363 PHE C 376 1 14 HELIX 34 34 ASN C 385 TYR C 408 1 24 HELIX 35 35 GLY C 413 LEU C 420 1 8 HELIX 36 36 LEU C 420 GLY C 443 1 24 HELIX 37 37 THR C 449 LEU C 455 1 7 HELIX 38 38 LYS C 478 LEU C 484 1 7 HELIX 39 39 PRO D 231 ALA D 241 1 11 HELIX 40 40 ASP D 263 ILE D 286 1 24 HELIX 41 41 PRO D 293 SER D 317 1 25 HELIX 42 42 HIS D 333 ALA D 340 1 8 HELIX 43 43 VAL D 342 LEU D 353 1 12 HELIX 44 44 LEU D 353 MET D 360 1 8 HELIX 45 45 ASP D 363 PHE D 376 1 14 HELIX 46 46 ASN D 385 TYR D 408 1 24 HELIX 47 47 GLY D 413 LEU D 420 1 8 HELIX 48 48 LEU D 420 GLY D 443 1 24 HELIX 49 49 ASP D 448 LEU D 455 1 8 HELIX 50 50 LYS D 478 LEU D 483 1 6 SHEET 1 A10 PHE A 292 ASN A 293 0 SHEET 2 A10 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 A10 LEU A 304 LEU A 308 -1 O LEU A 304 N CYS A 301 SHEET 4 A10 VAL A 211 ARG A 216 -1 N GLN A 214 O SER A 305 SHEET 5 A10 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 A10 VAL B 222 LYS B 226 -1 O ASN B 224 N ASN A 224 SHEET 7 A10 VAL B 211 ARG B 216 -1 N LEU B 215 O TRP B 223 SHEET 8 A10 LEU B 304 LEU B 308 -1 O CYS B 307 N SER B 212 SHEET 9 A10 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 A10 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 SHEET 1 B 2 ILE C 324 LEU C 325 0 SHEET 2 B 2 HIS C 331 VAL C 332 -1 O VAL C 332 N ILE C 324 SHEET 1 C 2 ILE D 324 LEU D 325 0 SHEET 2 C 2 HIS D 331 VAL D 332 -1 O VAL D 332 N ILE D 324 CISPEP 1 GLU A 458 GLY A 459 0 8.25 CISPEP 2 SER B 231 GLY B 232 0 -12.64 CISPEP 3 GLN B 383 PRO B 384 0 6.08 CISPEP 4 GLU B 458 GLY B 459 0 -0.12 SITE 1 AC1 4 THR A 422 PRO A 423 LEU A 424 SER C 339 SITE 1 AC2 3 PRO B 423 LEU B 424 SER D 339 CRYST1 70.260 109.550 169.880 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009128 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005887 0.00000